Cisplatin-based chemotherapy of primary extragonadal germ cell tumors: A single institution experience

Cancer

Volumn 77, Issue 3, 1996, Pages 526-532

  Gerl, Arthur ^a   Clemm, Christoph ^b   Lamerz, Rolf ^a   Wilmanns, Wolfgang ^a,c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Klinik Bad Trissl   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

chemotherapy; extragonadal germ cell tumor; nonseminoma; seminoma

Indexed keywords

ALPHA FETOPROTEIN; BLEOMYCIN; CARBOPLATIN; CHORIONIC GONADOTROPIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IFOSFAMIDE; TUMOR MARKER; VINBLASTINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL FEATURE; CLINICAL TRIAL; GERM CELL TUMOR; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM TUMOR; MEDICAL RECORD; NON SEMINOMATOUS GERMINOMA; ORCHIECTOMY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RADIODIAGNOSIS; RETROPERITONEAL TUMOR; SEMINOMA; SMALL INTESTINE PERFORATION; TESTIS BIOPSY; TREATMENT OUTCOME; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; CISPLATIN; GERMINOMA; HUMANS; MALE; MEDIASTINAL NEOPLASMS; RETROPERITONEAL NEOPLASMS; SEMINOMA;

EID: 0030063937     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960201)77:3<526::AID-CNCR15>3.0.CO;2-6     Document Type: Article

References (43)

1. Einhorn LH. Testicular cancer as a model for a curable neoplasm. Cancer Res 1981;41:3274-80.
2. Collins DH, Pugh RCB. Classification and frequency of testicular tumors. Br J Urol 1964;36(1 Suppl):1-11.
3. McAleer JJA, Nicholls J, Horwich A. Does extragonadal presentation impart a worse prognosis to abdominal germ-cell tumours? Eur J Cancer 1992;28A:825-8.
4. Willis RA. Borderland of embryology and pathology. 2nd edition. Washington DC: Butterworth and Co., Ltd., 1962:442.
5. Friedman NB. The function of primordial germ cell in extragonadal tissues. Int J Androl 1987;10:43-9.
6. Nichols CR, Saxman S, Williams SD, Loehrer PJ, Miller ME, Wright C, et al. Primary mediastinal nonseminomatous germ cell tumors. A modern single institution experience. Cancer 1990;65:1641-6.
7. Clemm C, Hartenstein R, Willich N, Ledderose G, Wilmanns W. Combination chemotherapy with vinblastine, ifosfamide and cisplatin in bulky seminoma. Acta Oncol 1989;28:231-5.
8. Gerl A, Clemm C, Lamerz R, Wilmanns W. Primary extragonadal nonseminomatous germ cell tumors: differential diagnosis and monitoring of treatment. Diagn Oncol 1991;1:269-76.
9. Gerl A, Clemm C, Kohl P, Niedermaier J, Schalhorn A. Primär extragonadale Keimzelltumoren. Klinisches Erscheinungsbild, Differentialdiagnose und Therapie. Med Klin 1994; 89:240-4.
10. Einhorn LH, Donohue JP. Combination chemotherapy with cisdiamminedichloroplatinum, vinblastine, and bleomycin in disseminated testicular cancer. Ann Intern Med 1977; 87:293-8.
11. Williams SD, Birch R, Einhorn LH, Irwin L, Greco FA, Loehrer PJ. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 1987;316:1435-40.
12. Gerl A, Clemm C, Lamerz R, Mann K, Wilmanns W. Prognostic implications of tumour marker analysis in non-seminomatous germ cell tumours with poor prognosis metastatic disease. Eur J Cancer 1993;29A:961-5.
13. Gerl A, Clemm C, Hentrich M, Hartenstein R, Wilmanns W. Etoposide, cisplatin, bleomycin and cyclophosphamide as first-line chemotherapy for poor-risk nonseminomatous germ cell tumors. Acta Oncol 1993;32:541-6.
14. Bokemeyer C, Schmoll H-J, Harstrick A, Illiger HJ, Metzner B, Räth U, et al. A phase I/II study of a stepwise do se-escalated regimen of cisplatin, etoposide and ifosfamide plus granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced germ cell tumours. Eur J Cancer 1993;29A:2225-31.
15. Clemm C, Hartenstein R, Willich N, Boening L, Wilmanns W. Vinblastine-ifosfamide-cisplatin treatment of bulky seminoma. Cancer 1986;58:2203-7.
16. Gerl A, Clemm C, Schmeller N, Dienemann H, Lamerz R, Kriegmair M, et al. Outcome analysis after post-chemotherapy surgery in patients with non-seminomatous germ cell tumours. Ann Oncol 1995;6:483-8.
17. Kersh CR, Constable WC, Hahn SS, Spaulding CA, Eisert DR, Jenrette JM, et al. Primary malignant extragonadal germ cell tumors. An analysis of the effect or radiotherapy. Cancer 1990;65:2681-5.
18. Dulmet EM, Macchiarini P, Sue B, Verley JM. Germ cell tumors of the mediastinum. A 30-year experience. Cancer 1993;72:1894-901.
19. Cox JD. Primary malignant germinal tumors of the mediastinum. Cancer 1975;36:1162-8.
20. Hainsworth JD, Einhorn LH, Williams SD, Stewart M, Greco FA, Advanced extragonadal germ-cell tumors. Successful treatment with combination chemotherapy. Ann Intern Med 1982;97:7-11.
21. Toner GC, Geller NL, Lin S-Y, Bosl GJ. Extragonadal and poor risk nonseminomatous germ cell tumors. Cancer 1991;67:2049-57.
22. Childs WJ, Goldstraw P, Nicholls JE, Dearnaley DP, Horwich A. Primary malignant mediastinal germ cell tumours: improved prognosis with platinum-based chemotherapy and surgery. Br J Cancer 1993;67:1098-1101.
23. Logothetis CJ, Samuels ML, Selig DE, Dexeus FH, Johnson DE, Swanson DA, et al. Chemotherapy of extragonadal germ cell tumors. J Clin Oncol 1985;3:316-25.
24. Hainsworth JD, Greco FA. Extragonadal germ cell tumors and unrecognized germ cell tumors. Semin Oncol 1992;19:119-27.
25. Carl J, Christensen TB, von der Maase H. Cisplatinum dose dependent response in germ cell cancer evaluated by tumour marker modelling. Acta Oncol 1992;31:749-53.
26. Kuzur ME, Cobleigh MA, Greco FA, Einhorn LH, Oldham RK. Endodermal sinus tumor of the mediastinum: a report of seven cases and review of the literature. Cancer 1982;50:766-74.
27. Sham JST, Fu KH, Chiu CSW, Lau WH, Choi PHK, Khin MA, et al. Experience with the management of primary endodermal sinus tumor of the mediastinum. Cancer 1989;64:756-61.
28. Chong CDK, Logothetis CJ, von Eschenbach AC, Ayala AG, Samuels ML. Successful treatment of pure endodermal sinus tumors in adult men. J Clin Oncol 1988;6:303-7.
29. Nichols CR, Roth BJ, Heerema N, Griep J, Tricot G. Hematologic neoplasia associated with primary mediastinal germ-cell tumors. N Engl J Med 1990;322:1425-9.
30. Vlasveld LT, Splinter AW, Hagemeijer A, Van Lorn K, Löwenberg B. Acute myeloid leukaemia with +i(12p) shortly after treatment of mediastinal germ cell tumour. Br J Haematol 1994;88:196-8.
31. Bukowski RM, Wolf M, Kulander BG, Montie J, Crawford D, Blumenstein B. Alternating combination chemotherapy in patients with extragonadal germ cell tumors. Cancer 1993;71:2631-8.
32. Daugaard G, Rorth M, von der Maase H, Skakkebaek NE. Management of extragonadal germ-cell tumors and the significance of bilateral testicular biopsies. Ann Oncol 1992;3:283-9.
33. Harding MJ, Paul J, Gillis CR, Kaye SB. Management of malignant teratoma: does referral to a specialist unit matter? Lancet 1993;341:999-1002.
34. Saxman SB, Nichols CR, Einhorn LH. Salvage chemotherapy in patients with extragonadal nonseminomatous germ cell tumors: the Indiana University experience. J Clin Oncol 1994;12:1390-3.
35. Motzer RJ, Geller NL, Tan CC-Y, Herr H, Morse M, Fair W, et al. Salvage chemotherapy for patients with germ cell tumors. The Memorial Sloan-Kettering Cancer Center experience. Cancer 1991;67:1305-10.
36. Gerl A, Clemm C, Schmeller N, Hartenstein R, Lamerz R, Wilmanns W. Prognosis after salvage treatment for unselected male patients with germ cell tumors. Br J Cancer. 1995;72:1026-32.
37. Goss PE, Schwertfeger L, Blackstein ME, Iscoe NA, Ginsberg RJ, Simpson WJ, et al. Extragonadal germ cell tumors. A 14-year Toronto experience. Cancer 1994;73:1971-9.
38. Mencel PJ, Motzer RJ, Mazumdar M, Vlamis V, Bajorin DF, Bosl GJ. Advanced seminoma: treatment results, survival, and prognostic factors in 142 patients. J Clin Oncol 1994;12:120-6.
39. Fossa SD, Droz JP, Stoter G, Kaye SB, Vermeylen K, Sylvester R, et al. Cisplatin, vincristine and ifosphamide combination chemotherapy of metastatic seminoma: results of EORTC trial 30874. Br J Cancer 1995;71:619-24.
40. Horwich A, Dearnaley DP, Duchesne GM, Williams M, Brada M, Peckham MJ. Simple nontoxic treatment of advanced metastatic seminoma with carboplatin. J Clin Oncol 1989;7:1150-6.
41. Schmoll H-J, Harstrick A, Bokemeyer C, Dieckmann K-P, Clemm C, Berdel WE, et al. Single-agent carboplatinum for advanced seminoma. A phase II study. Cancer 1993;72:237-43.
42. Motzer RJ, Bosl G, Heelan R, Fair W, Whitmore W, Sogani P, et al. Residual mass: an indication for further therapy in patients with advanced seminoma following systemic chemotherapy. J Clin Oncol 1987;5:1064-70.
43. Schultz SM, Einhorn LH, Conces DJ, Williams SD, Loehrer PJ. Management of postchemotherapy residual mass in patients with advanced seminoma: Indiana University experience. J Clin Oncol 1989;7:1497-1503.